Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223493 · ClinicalTrials.gov registry record
Awareness, Care & Treatment in Obesity Management (ACTION) Study
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 3,767
- Enrollment target
NCT03223493: Completed study, sponsored by Novo Nordisk A/S.
NCT03223493 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 3,767 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03223493 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 3,767 participants
- Enrollment target
Study Summary
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.
Primary Outcome
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,767 participants |
| Start Date | 2015-10-29 |
| Est. Completion | 2015-11-12 |
What the finished NCT03223493 record still lists
NCT03223493 is an observational study that tracks outcomes without assigning an intervention. Its 3,767 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT03223493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03223493 about?
NCT03223493 is a clinical study titled "Awareness, Care & Treatment in Obesity Management (ACTION) Study". The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data...
What is the current status of trial NCT03223493?
This trial is currently completed. The enrollment target is 3,767 participants. The study started on 2015-10-29. Estimated completion is 2015-11-12.
What interventions are being tested in trial NCT03223493?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03223493?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI